T100-Mut

T100-Mut

Catalog Number:
P004516701LIF
Mfr. No.:
PEPTIDE-PP-190
Price:
$381
  • Size:
    1mg
    Quantity:
    Add to Cart:
      • Overview
        • Enhances the association of TRPA1 and TRPV1.
          T100-Mut is a cell permeable peptide which enhances the association of TRPA1 and TRPV1 and strongly inhibits TRPA1 associated pain. The design of T100-Mut originated from Tmem100, a 134-amino acid protein found in dorsal root ganglia (DRG), co-expressed with TRPA1 and TRPV1 with which it forms a complex. Tmem100 decreases the interaction between TRPA1 and TRPV1, whereas a Tmem100 mutant, Tmem100-3Q, exerts the opposite effect and enhances the association of TRPA1 and TRPV1 to inhibit TRPA1. T100-Mut contains the C-terminal sequence of Tmem100-3Q and mimicks the effect of full-length Tmem100-3Q, inhibiting TRPA1-mediated activity and pain in a TRPV1-dependent manner. T100-Mut is also effective in animal models of pain.

          Please contact us for availability.

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          Cell Penetrating Peptides
          Molecular Formula
          C109H186N34O30
          Molecular Weight
          2451.8
          Appearance
          Freeze dried solid
          Purity
          >95% by HPLC
          Solubility
          Soluble in DMSO
          Other Properties
          Sequence: Myr-Trp-Lys-Val-Arg-Gln-Arg-Asn-Lys-Lys-Val-Gln-Gln-Gln-Glu-Ser-Gln-Thr-Ala-Leu-Val-Val-Asn-Gln-Arg-Cys-Leu-Phe-Ala-OH,Myr-WKVRQRNKKVQQQESQTALVVNQRCLFA
          Modification: Myristoyl group at N terminal
          Storage
          Store desiccated, frozen and in the dark

          * Please note: this product can only be supplied to registered research and development facilities, and may be used for in vitro research use only, not for administration to humans or animals.

    We Also Recommend

    TAT 2-4

    $275

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.